Ovarian cancer treatment usually involves removing both ovaries – a procedure called bilateral salpingo-oophorectomy – along with platinum-based chemotherapy. This stops estrogen production right away. Unlike natural menopause, which happens slowly over years, treatment-induced menopause is sudden and permanent for most younger survivors. The result is frequent night sweats, hot flashes, disrupted sleep, and bone loss. This article covers ways to manage these symptoms, including non-hormonal medications, behavioral changes, and sleep support.
What Causes Chemo-Induced Menopause in Ovarian Cancer Survivors
When both ovaries are removed, the main source of estrogen is gone. A review in BMC Cancer describes how estrogen drops sharply after ovarian surgery – more than what happens during natural menopause. This sudden change causes immediate hot flashes, night sweats, and insomnia, along with changes to vaginal tissue and bone density.
Chemotherapy makes it worse. Platinum-based drugs like carboplatin can damage remaining ovarian tissue, even if some ovary remains. For younger women, this usually causes permanent ovarian failure. The National Cancer Institute (NCI) shows that hot flashes and night sweats are among the most common and most distressing side effects of cancer treatment across all cancer types, including ovarian cancer.
| Comparison Axis | Venlafaxine (SNRI) | Gabapentin | Melatonin 3 mg nightly |
|---|---|---|---|
| Typical dose studied | 75 mg/day | 900 mg/day | 3 mg nightly |
| Requires prescription | Yes | Yes | No |
| Primary benefit studied | Hot flash and night sweat reduction | Hot flash and night sweat reduction | Sleep quality improvement |
| Reduction in hot flash score (RCT) | ~66% | ~66% | Not significant vs. placebo |
| Common reported side effects | Nausea, appetite changes, constipation | Dizziness | Drowsiness if timed incorrectly |
Sources: Bordeleau et al., J Clin Oncol 2010 (randomized crossover trial, breast cancer survivors, n=66) for venlafaxine and gabapentin figures; Crew et al., JNCI 2014 (randomized placebo-controlled trial, breast cancer survivors, n=95) for melatonin figures. Individual results vary.
How Severe Are Night Sweats After Ovarian Cancer Treatment?
Hot flashes and night sweats in ovarian cancer survivors are usually more severe than in natural menopause because the hormone change is faster and more complete. Hot flash and night sweat episodes can last 2 to 4 minutes and happen several times each night, breaking up sleep repeatedly. A 2025 review of menopause management in gynecologic cancer survivors found that about 25% of patients went into treatment-induced menopause early, and most reported serious distress from hot flashes, night sweats, sleep loss, and sexual dysfunction. Sleep loss from night sweats can affect concentration, mood, and physical recovery – all important concerns in the months and years following ovarian cancer treatment.
Is Hormone Replacement Therapy an Option After Ovarian Cancer?
Estrogen-based hormone replacement therapy (HRT) is the most effective treatment for hot flashes and night sweats. In ovarian cancer survivors, the safety question is different than with breast cancer. Most epithelial ovarian cancers do not rely on estrogen the way that hormone-sensitive breast cancers do. The BMC Cancer review cited above found no evidence that using systemic HRT reduced survival in epithelial ovarian cancer survivors, though the evidence is limited. The NCI summary on HRT and ovarian cancer survival is cautious but not opposed, noting that we don’t have enough randomized trial data and individual risk assessment is important.
Whether HRT is appropriate depends on tumor type, grade, stage, time since treatment, age, and whether you’re taking antiestrogen drugs. This decision belongs with a gynecologic oncologist or a menopause specialist with cancer experience.
Non-Hormonal Prescription Approaches to Night Sweats
Several non-hormonal drugs with prescription have evidence from randomized trials that they reduce hot flashes and night sweats in cancer survivors. These require a prescription and each has its own side effects. The information below is meant to help you talk with your doctor, not to be a guide for taking these drugs on your own.
Venlafaxine (SNRI), 75 mg per day. A randomized trial in the Journal of Clinical Oncology compared venlafaxine 75 mg per day directly with gabapentin 900 mg per day in 66 breast cancer survivors. Both reduced hot flash scores by about 66%. Of those who had a preference, 68% preferred venlafaxine. Side effects with venlafaxine included nausea, appetite changes, and constipation. The full trial results are on PubMed.
Gabapentin, 900 mg per day. Gabapentin had about the same effect on hot flash scores in the same trial. Dizziness was the most commonly reported side effect. Doctors may use gabapentin when antidepressants don’t work well, and some doctors use it when better sleep at night is also important. You need a doctor’s guidance on dose and timing. The NCI PDQ on hot flashes and night sweats recognizes both types of drugs as proven non-hormonal choices for cancer-related hot flashes and night sweats. That summary is free and updated often.
Behavioral and Lifestyle Approaches
Non-drug strategies are a standard part of survivorship guidelines for hot flashes and night sweats. Most have little risk and can be combined with medications.
- Cognitive behavioral therapy for insomnia (CBT-I). The Menopause after Cancer (MAC) study, a randomized trial, found that digital CBT-I combined with skills to manage hot flushes improved cancer-related quality of life, sleep problems, and hot flush frequency and bother. CBT-I is available through trained therapists, cancer center survivorship clinics, and proven digital programs.
- Paced breathing. Slow, deep breathing practiced during a hot flash is a common recommendation in cancer hot flush programs. Small trials suggest it may reduce how intense the hot flash feels.
- Cooling strategies. The American Cancer Society recommends keeping your bedroom cool, using a fan, and wearing loose cotton clothes or moisture-wicking blankets to reduce night sweat discomfort.
- Trigger tracking. Caffeine, alcohol, spicy foods, and hot drinks are common triggers for hot flashes and night sweats. Keeping a symptom diary for 2 to 4 weeks can help you find personal patterns worth changing.
- Regular exercise. Aerobic and weight training have been linked to small reductions in hot flashes and night sweats and better sleep in cancer survivors. The improvements are modest, but exercise helps cancer survivors’ overall health in many ways.
Melatonin for Sleep Disruption Caused by Night Sweats
Even when hot flashes and night sweats decrease, fragmented sleep can continue to be a problem. Melatonin is one of the most studied supplements for sleep quality in cancer survivors.
A randomized, placebo-controlled trial of 95 postmenopausal breast cancer survivors compared 3 mg melatonin taken at night to placebo for 4 months. Compared with placebo, the melatonin group had greater improvements in sleep quality on the Pittsburgh Sleep Quality Index, including overall sleep quality and daytime function. Hot flash frequency was not different between groups. The researchers chose 3 mg because it raises melatonin levels at night but returns to normal by morning, to avoid next-day drowsiness. The full trial is on the NIH National Library of Medicine website. This study used breast cancer survivors; the findings may help ovarian cancer survivors with similar hormone loss, but melatonin has not been tested specifically in an ovarian cancer survivor population. Talk to your oncologist or pharmacist about timing and dose before you start.
Bone Health: A Secondary Effect of Sudden Estrogen Loss
Estrogen plays a key role in bone remodeling. When estrogen levels drop quickly – as they do after ovarian cancer surgery and chemotherapy – bone turnover speeds up and bone mineral density can decline fast. A 2025 systematic review found that ovarian cancer survivors face higher fracture risk compared with the general population, particularly at the hip, spine, and forearm.
Dual-energy X-ray absorptiometry (DEXA) scanning is a standard part of ovarian cancer follow-up. Survivorship guidelines generally recommend getting 1,000 to 1,200 mg of calcium per day from food and supplements, with vitamin D dose adjusted to a blood level that your care team thinks is enough – usually checked with an annual blood test. Weight-bearing and resistance exercise are also recommended. For more details on protecting bone health in hormone-deprived cancer survivors, see Preventing Bone Loss During Aromatase Inhibitor Therapy, which covers similar issues and monitoring.
Vaginal Health and Sexual Comfort
Low estrogen also causes changes to vaginal tissue – dryness, thinning, and less lubrication – that affect sexual comfort and can lead to urinary urgency. Low-dose topical vaginal estrogen has minimal systemic absorption and doctors consider it appropriate for most women with epithelial ovarian cancer who are not taking antiestrogen drugs. Each case should be reviewed individually by a doctor, and this option is different from systemic HRT. Survivors dealing with changes to identity and intimacy after ovarian cancer may find more perspective in Reclaiming Identity After Ovarian Cancer Fertility Loss.
Building a Survivorship Plan Around Menopausal Symptoms
Night sweats and related menopausal symptoms are important but you can manage them with the right combination of strategies. Hot flashes and night sweats typically get worse in the first 6 to 12 months after treatment and then gradually get better, though some survivors have ongoing symptoms for several years. Keeping a symptom log – writing down how often they happen, how bad they are, how long they last, and what might cause them – gives your doctor concrete information to guide treatment decisions and see if something is working.
Formal survivorship care planning, available at most comprehensive cancer centers, typically covers hot flash and night sweat management, bone density monitoring, sexual health, and referrals to menopause specialists with cancer experience. If your care team has not provided a written survivorship plan, asking for one is a reasonable next step. If you’re interested in supplements to use with your cancer treatment, talk with your care team about safe options and ingredients.
If you are taking prescription medications, or if you are pregnant or breastfeeding, talk to a doctor before adding any supplement or changing your treatment plan.
This article gives general information and is not a substitute for medical advice. Always talk with your oncologist or care team about your specific situation.
